254
Views
21
CrossRef citations to date
0
Altmetric
Original research

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

, MD PhD, , MD, , MD, , MD & , MD
Pages 3145-3149 | Published online: 04 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Zeinab Sadat Ayatollahi, Mehran Shayganfard, Hamidreza Jamilian & Anita Alaghmand. (2022) Comparing the efficacy of aripiprazole as an add-on to valproate with other second-generation antipsychotics in acute mania symptoms in manic patients in Iran. International Journal of Psychiatry in Clinical Practice 26:4, pages 363-369.
Read now
Young Sup Woo, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, Inki Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Young-Chul Shin, Kyung Joon Min, Bo-Hyun Yoon & Won-Myong Bahk. (2015) Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsychiatric Disease and Treatment 11, pages 493-506.
Read now
Ibrahim Eren, Arif Demirdas & Ikbal Civi Inanli. (2014) Evaluating The Antidepressant Efficacy of Aripiprazole Using a Chronic Mild Stress Model: An Experimental Study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 24:1, pages 15-22.
Read now

Articles from other publishers (18)

Frederike T. Fellendorf, Edoardo Caboni, Pasquale Paribello, Martina Pinna, Ernesto D’Aloja, Sara Carucci, Federica Pinna, Eva Z. Reininghaus, Bernardo Carpiniello & Mirko Manchia. (2023) Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies. Pharmaceuticals 16:2, pages 182.
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 247 304 .
Frederick “Fritz” T. Fraunfelder & Frederick “Rick” W. Fraunfelder. 2021. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects 87 141 .
Dana Wang & David N. Osser. (2019) The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on bipolar depression. Bipolar Disorders 22:5, pages 472-489.
Crossref
Luke A. Jelen & Allan H. Young. (2020) The Treatment of Bipolar Depression: Current Status and Future Perspectives. Current Behavioral Neuroscience Reports 7:1, pages 1-14.
Crossref
In Hee Shim, Young Sup Woo & Won-Myong Bahk. (2016) Associations between immune activation and the current severity of the “with anxious distress” specifier in patients with depressive disorders. General Hospital Psychiatry 42, pages 27-31.
Crossref
Rao N. Malempati. (2015) Aripiprazole Adjunct Treatment in Bipolar I or II Disorder, Depressed State. Journal of Nervous & Mental Disease 203:1, pages 58-64.
Crossref
. 2015. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects 47 343 .
Isaac Schweitzer, Jerome Sarris, Virginia Tuckwell, Kay Maguire, Deidre Smith & Chee Ng. (2013) Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms. International Journal of Bipolar Disorders 1:1.
Crossref
Andrea de Bartolomeis, Livia Avvisati, Felice Iasevoli & Carmine Tomasetti. (2013) Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment. European Journal of Pharmacology 718:1-3, pages 502-523.
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen & Michael Berk. (2012) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders 15:1, pages 1-44.
Crossref
P.-M. Llorca. (2011) Antipsychotiques de seconde génération dans la dépression bipolaire : une nouvelle option thérapeutique ?. L'Encéphale 37, pages S209-S213.
Crossref
Alessandra Nivoli & Eduard Vieta. 2011. Bipolar Psychopharmacotherapy. Bipolar Psychopharmacotherapy 245 269 .
Carmine Tomasetti, Carmela Dell'Aversano, Felice Iasevoli, Federica Marmo & Andrea de Bartolomeis. (2011) The acute and chronic effects of combined antipsychotic–mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:1, pages 184-197.
Crossref
Martin A. Katzman. (2011) Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness. Journal of Affective Disorders 128, pages S11-S20.
Crossref
Alfonso Carvajal, Luis H. Martín Arias & Natalia Jimeno. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 89 123 .
Silvio Bellino, Camilla Rinaldi & Filippo Bogetto. (2010) Adaptation of Interpersonal Psychotherapy to Borderline Personality Disorder: A Comparison of Combined Therapy and Single Pharmacotherapy. The Canadian Journal of Psychiatry 55:2, pages 74-81.
Crossref
Konstantinos N Fountoulakis & Eduard Vieta. (2009) Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Annals of General Psychiatry 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.